Status:
COMPLETED
The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial
Lead Sponsor:
General Hospital of Ningxia Medical University
Conditions:
Loss of Consciousness
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effects of different dexmedetomidine on the propofol requirement for loss of consciousness undergoing bispectral index.
Detailed Description
It has been shown that dexmedetomidine was an efficacious and safe adjuvant in general anaesthesia. Administration of dexmedetomidine during the preoperative period has been demonstrated to reduce the...
Eligibility Criteria
Inclusion
- ASA physical status I-II
- Aged 18-65 years
- Body Mass Index 18.0～24.5 kg/m2
- Without hearing impairment
Exclusion
- Bradycardia
- Atrioventricular block
- Neurologic disorder and recent use of psychoactive medication
- Allergic to the drugs
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT02783846
Start Date
June 1 2016
End Date
August 1 2016
Last Update
November 8 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.